CLRB - Cellectar Biosciences, Inc.
2.75
-0.010 -0.364%
Share volume: 114,458
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 10-29-2024 | 10-29-2024 | 11-18-2024 | 03-13-2025 | 05-13-2025 | 08-14-2025 | 11-13-2025 | 03-04-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 12.001 M | 13.704 M | 13.328 M | 12.745 M | 6.401 M | 6.038 M | 4.851 M | 5.691 M | |
| Selling general and admin | 4.913 M | 6.358 M | 7.834 M | 6.536 M | 2.974 M | 3.648 M | 2.327 M | 2.532 M | |
| Research and development | 7.088 M | 7.345 M | 5.493 M | 6.209 M | 3.427 M | 2.390 M | 2.523 M | 3.159 M | |
| Total expenses | 12.001 M | 13.704 M | 13.328 M | 12.745 M | 6.401 M | 6.038 M | 4.851 M | 5.691 M | |
| 14.18% | -2.74% | -4.37% | -49.78% | -5.68% | -19.66% | 17.32% | |||
| Operating income | -12.001 M | -13.704 M | -13.328 M | -12.745 M | -6.401 M | -6.038 M | -4.851 M | -5.691 M | |
| Ebit | -26.962 M | -1.248 M | -14.983 M | -2.534 M | -6.741 M | -5.536 M | -4.556 M | -5.393 M | |
| Pretax income | 0.000 | -919.371 K | -14.665 M | -28.931 M | -6.604 M | -5.448 M | -4.444 M | -5.295 M | |
| inf% | 1,495.08% | 97.29% | -77.17% | -17.51% | -18.43% | 19.16% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -26.642 M | -919.371 K | -14.665 M | -2.355 M | -6.604 M | -5.448 M | -4.444 M | -5.295 M | |
| 96.55% | -1,495.08% | 83.94% | -180.38% | 17.51% | 18.43% | -19.16% |